Zycos Incorporated

ZYCOS Inc. is a drug development company that is focused on converting genetic information into drugs, faster. The company's proprietary technology platform is comprised of gene expression vectors, polymer delivery systems and unique methods of antigen discovery and optimization. Integrating its technologies and in-house expertise, the company has formed a "plug and play" process to validate and optimize gene targets and formulate gene-based drugs. ZYCOS believes it can offer partners who have multiple gene targets in development, an accelerated path to the clinic.

Contact Details: 44 Hartwell Avenue Lexington MA 02421 United States of America Tel: 781 274 6500 Fax: 781 274 0839 Email: info@zycos.com WWW: www.zycos.com/

Loading...

Recent Publications by Zycos Incorporated:
Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1. Injection of microparticle-encapsulated DNA elicits immune responses to...	20th August, 2004	Zycos, Inc., Lexington, MA 02421, USA.	Clin Immunol. 2004 Jul;112(1):45-53. DOI Direct Link
Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors. DNA expression vectors have the potential to be useful therapeutics for a...	22nd July, 2004	ZYCOS, Inc., 44 Hartwell	Expert Opin Biol Ther. 2003 Sep;3(6):903-10. DOI Direct Link
Microparticle delivery of plasmid DNA to mammalian cells. Injection of microparticle-encapsulated DNA elicits immune responses to...	14th February, 2004	ZYCOS Inc., Lexington, MA, USA.	Methods Mol Biol. 2004;245:265-86.
Microcapillary liquid chromatography/tandem mass spectrometry using alkaline pH mobile phases and positive ion detection. Extending the dynamic range of microcapillary liquid chromatography/tandem...	17th June, 2003	Discovery Research, ZYCOS Inc, Lexington, MA 02421, USA.	Rapid Commun Mass Spectrom. 2003;17(9):909-16. DOI Direct Link
Generation of expression constructs that secrete bioactive alphaMSH and their use in the treatment of experimental autoimmune encephalomyelitis. alpha Melanocyte-stimulating hormone (alphaMSH) is a 13 amino acid peptide...	15th April, 2003	Zycos Inc, Lexington, MA 02421, USA.	Gene Ther. 2003 Feb;10(4):348-55. DOI Direct Link
→View more Zycos Incorporated research publications.

BioNews Results for Zycos Incorporated:
Bruker Corporation Appoints William J. Knight to Chief Operating Officer and Brian P. Monahan to Chief Financi	Pharma Live:  Nov 9 2009 6:36PM Matching: zycos
Bruker Corporation Appoints William J. Knight to Chief Operating Officer and Brian P. Monahan to Chief Financi	Genetic Engineering News:  Nov 9 2009 1:08PM Matching: zycos
Bruker Corporation Appoints William J. Knight to Chief Operating Officer and Brian P. Monahan to Chief Financial Officer	Yahoo! Canada:  Nov 9 2009 12:56PM Matching: zycos

Zycos Incorporated Patents:
US Patent No.	Title
6582704	Immunogenic peptides from the HPV E7 protein
6562943	Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
6183746	Immunogenic peptides from the HPV E7 protein
6013258	Immunogenic peptides from the HPV E7 protein

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 754 times since April 2007, the link to the organisation's website has been followed 153 times

Recent Search Terms used to find this page: Zycos lexington ma | Zycos | alpha-MSH Zycos | zycos incorporated | Zycos Gene delivery | zycos lexington | zycos | .

Search for more companies in Lexington

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Zycos Incorporated